Novartis argued that better physicochemical qualities, such as shape of the molecule, stability, hygroscopicity and solubility, would satisfy the test of enhanced efficacy.

DNA damage or other physicochemical stresses may increase the expression of major histocompatibility complex class I–related stress antigens, which then activate lymphocytes.

But the physicochemical effect that it induces at a synapse must be different in kind.